RMR Wealth Builders’s Microbot Medical MBOT Stock Holding History

RMR Wealth Builders’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1	Closed	–	–	801
2020 Q4	$0	Buy	+1	New	+$8	﹤0.01%	540

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $100M AUM

XXEC Inc Tulsa, Oklahoma $571M AUM 1.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RMR Wealth Builders's MBOT Position: Q1 2021 in Review

RMR Wealth Builders sold out of Microbot Medical (MBOT) in Q1 2021, closing a stake of 1 share.

RMR Wealth Builders first reported a position in MBOT in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 25 funds tracked by Wall St. Rank hold MBOT as of Q1 2021.

RMR Wealth Builders reported no remaining Microbot Medical position as of Q1 2021 after selling out during the quarter.
RMR Wealth Builders sold 1 Microbot Medical share in Q1 2021.
RMR Wealth Builders first reported a position in Microbot Medical in Q4 2020 and held it in 1 quarter.
RMR Wealth Builders's Microbot Medical position peaked at $0 in Q4 2020.
25 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2021.

Based on RMR Wealth Builders's 13F filing for Q1 2021, filed 13 May 2021.